Two Sigma Advisers
CLOV icon

Two Sigma Advisers’s Clover Health Investments CLOV Stock Holding History

Two Sigma Advisers’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,900
Closed -$67.9K – 2344
2025
Q1 		$67.9K Sell
18,900
-5,800
-23% -$23.3K ﹤0.01% 2288
2024
Q4 		$77.8K Buy
+24,700
New +$88.3K ﹤0.01% 2247
2024
Q3 		– Sell
-58,400
Closed -$71.8K – 2320
2024
Q2 		$71.8K Sell
58,400
-704,600
-92% -$632K ﹤0.01% 2337
2024
Q1 		$606K Sell
763,000
-1,050,312
-58% -$956K ﹤0.01% 1793
2023
Q4 		$1.73M Buy
1,813,312
+1,800,512
+14,067% +$1.77M ﹤0.01% 1374
2023
Q3 		$13.8K Buy
+12,800
New +$15.2K ﹤0.01% 2337
2023
Q2 		– Sell
-30,000
Closed -$25.4K – 2419
2023
Q1 		$25.4K Buy
+30,000
New +$32.8K ﹤0.01% 2506
2022
Q4 		– Sell
-719,700
Closed -$1.22M – 2535
2022
Q3 		$1.22M Sell
719,700
-2,161,000
-75% -$5.66M ﹤0.01% 1424
2022
Q2 		$6.17M Sell
2,880,700
-1,867,100
-39% -$4.96M 0.02% 680
2022
Q1 		$16.9M Buy
4,747,800
+369,100
+8% +$1.07M 0.04% 360
2021
Q4 		$16.3M Buy
4,378,700
+4,340,800
+11,453% +$26.6M 0.04% 359
2021
Q3 		$280K Buy
+37,900
New +$324K ﹤0.01% 2139

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Advisers's CLOV Position: Q2 2025 in Review

Two Sigma Advisers sold out of Clover Health Investments (CLOV) in Q2 2025, closing a stake of 18,900 shares — an estimated $67.9K sold.

Two Sigma Advisers first reported a position in CLOV in Q3 2021 and held it in 12 quarters. The position peaked at $16.9M in Q1 2022. 200 funds tracked by Wall St. Rank hold CLOV as of Q2 2025.

  • Two Sigma Advisers reported no remaining Clover Health Investments position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 18,900 Clover Health Investments shares in Q2 2025, an estimated $67.9K.
  • Two Sigma Advisers first reported a position in Clover Health Investments in Q3 2021 and held it in 12 quarters.
  • Two Sigma Advisers's Clover Health Investments position peaked at $16.9M in Q1 2022.
  • 200 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2025.

Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.